About Immunoglobulin superfamily member 21
Immunoglobulin superfamily member 21 (IGSF21) is a protein
from Homo sapiens identified by UniProt accession
Q96ID5, 467 residues long.
MolForge cross-references it against 0 known binders and
34 disease associations.
Target properties
| Protein name | Immunoglobulin superfamily member 21 |
| UniProt accession | Q96ID5 |
| Gene | IGSF21 |
| Organism | Homo sapiens |
| Length | 467 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (34)
Diseases linked to this target (Open Targets).
- protein measurement · score 0.43
- smoking status measurement · score 0.37
- self reported educational attainment · score 0.36
- neurofibrillary tangles measurement · score 0.32
- viral load · score 0.31
- smoking cessation · score 0.30
- antisocial behaviour measurement · score 0.30
- attention deficit hyperactivity disorder · score 0.30
- smoking initiation · score 0.30
- substance abuse · score 0.30
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q96ID5-F1 | alphafold | PREDICTED | 76.59 | — |
Amino-acid sequence (467 residues)
MRTAPSLRRC VCLLLAAILD LARGYLTVNI EPLPPVVAGD AVTLKCNFKT DGRMREIVWY RVTDGGTIKQ KIFTFDAMFS TNYSHMENYR KREDLVYQST VRLPEVRISD NGPYECHVGI YDRATREKVV LASGNIFLNV MAPPTSIEVV AADTPAPFSR YQAQNFTLVC IVSGGKPAPM VYFKRDGEPI DAVPLSEPPA ASSGPLQDSR PFRSLLHRDL DDTKMQKSLS LLDAENRGGR PYTERPSRGL TPDPNILLQP TTENIPETVV SREFPRWVHS AEPTYFLRHS RTPSSDGTVE VRALLTWTLN PQIDNEALFS CEVKHPALSM PMQAEVTLVA PKGPKIVMTP SRARVGDTVR ILVHGFQNEV FPEPMFTWTR VGSRLLDGSA EFDGKELVLE RVPAELNGSM YRCTAQNPLG STDTHTRLIV FENPNIPRGT EDSNGSIGPT GARLTLVLAL TVILELT
Explore Immunoglobulin superfamily member 21 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets